fda regulations on semaglutide for weight loss | Blog FDA approves Ozempic® (semaglutide) as

You know your growth hormone levels decline with age research suggests output can drop by more than half between your 20s and your 60s

However, both drugs have caused similar health complications, prompting attorneys to group lawsuits involving Ozempic and Wegovy into multi-district litigation based on reports of severe risks such as vision loss, optic nerve damage, and gastrointestinal issues

The active ingredient in both of these medications is semaglutide

Muscle Cramping on GLP-1 Drugs: Which Medications Cause or Treat It At a glance Muscle cramps affect an estimated 2-4% of GLP-1 users in clinical trial populations GI side effects (nausea, vomiting, diarrhea) drive electrolyte depletion, the primary cramp trigger Magnesium, potassium, and sodium losses are the most common electrolyte deficits involved Diuretics, statins, and PPIs co-prescribed with GLP-1s compound cramping risk Rapid weight loss at rates above 1 kg per week increases muscle-related complaints Lab panel (BMP, magnesium, phosphorus) is the first diagnostic step Magnesium glycinate 200-400 mg nightly is a first-line supplement intervention Most cramps resolve within 2-4 weeks of targeted electrolyte correction Dose reduction or slower titration of the GLP-1 may be necessary in refractory cases Why GLP-1 Drugs Trigger Muscle Cramps Muscle cramping during GLP-1 receptor agonist therapy is not a direct pharmacologic effect of the drug on skeletal muscle

The government department doesn't give a timeline regarding when generic forms of these drugs will be approved, but Mina Tadrous, associate professor of pharmacy at the University of Toronto, told CBC News that generics might be available by this summer or early fall